Growth Metrics

Merck (MRK) Cash & Equivalents (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -63.43%
Dec 31, 2025 -19.84%
Sep 30, 2025 126.91%
Jun 30, 2025 -7.21%
Mar 31, 2025 -34.84%
Dec 31, 2024 -9.26%
Sep 30, 2024 29.10%
Jun 30, 2024 102.62%
Mar 31, 2024 -18.45%
Dec 31, 2023 -20.50%
Sep 30, 2023 52.03%
Jun 30, 2023 -41.69%
Mar 31, 2023 -23.53%
Dec 31, 2022 13.90%
Sep 30, 2022 15.19%
Jun 30, 2022 13.08%
Mar 31, 2022 5.68%
Dec 31, 2021 -19.17%
Sep 30, 2021 16.80%
Jun 30, 2021 22.83%
Mar 31, 2021 -13.28%
Dec 31, 2020 9.43%
Sep 30, 2020 -33.75%
Jun 30, 2020 49.54%
Mar 31, 2020 -23.26%
Dec 31, 2019 22.96%
Sep 30, 2019 18.17%
Jun 30, 2019 -17.55%
Mar 31, 2019 1.39%
Dec 31, 2018 1.78%
Sep 30, 2018 47.38%
Jun 30, 2018 18.45%
Mar 31, 2018 -26.41%
Dec 31, 2017 -22.90%
Sep 30, 2017 1.48%
Jun 30, 2017 -33.50%
Mar 31, 2017 79.71%
Dec 31, 2016 -17.60%
Sep 30, 2016 19.66%
Jun 30, 2016 -31.99%
Mar 31, 2016 13.98%
Dec 31, 2015 12.93%
Sep 30, 2015 9.04%
Jun 30, 2015 -13.26%
Mar 31, 2015 7.24%
Dec 31, 2014 -34.56%
Sep 30, 2014 16.70%
Jun 30, 2014 -38.44%
Mar 31, 2014 1.33%
Dec 31, 2013 10.87%
Sep 30, 2013 -6.63%
Jun 30, 2013 15.86%
Mar 31, 2013 -3.17%
Dec 31, 2012 -22.52%
Sep 30, 2012 3.63%
Jun 30, 2012 14.30%
Mar 31, 2012 8.31%
Dec 31, 2011 1.74%
Sep 30, 2011 7.76%
Jun 30, 2011 5.53%
Mar 31, 2011 7.29%
Dec 31, 2010 10.39%
Sep 30, 2010 13.94%
Jun 30, 2010 5.22%
Mar 31, 2010 -11.55%
Dec 31, 2009 -57.32%
Sep 30, 2009 75.13%
Jun 30, 2009 107.04%